Collegium Pharm Inc Drug Patent Portfolio

Collegium Pharm Inc's Family Patents


Family Patents



Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Collegium Pharm Inc News

Q3 Review of Branded Pharmaceutical Stocks: Analyzing Corcept (NASDAQ:CORT) Performance

13 Nov, 2025

Key Highlights for Branded Pharmaceutical Stocks in Q2: Collegium Pharmaceutical (NASDAQ:COLL)

25 Sep, 2025

Collegium Pharmaceutical Inc (COLL) has experienced a 0.99% increase in one week, is it a good idea to consider accumulating shares?

17 Jan, 2024

See More